3 Rs: Reduction

FDA needs to get with the picture: Bayesian statistical methods could bring clinical (and preclinical) trials into the 21st century.

The authors of this study suggest that a different way of looking at trial design would reduce the number of subjects needed for trials and reduce the risk for those who are used as subjects.

Bayesian statistics overview
Bayesian statistics for the statistically inclined